Summit Therapeutics Inc [SMMT] Investment Appeal on the Rise
In a filing, Summit Therapeutics Inc revealed its Chief Executive Officer Zanganeh Mahkam acquired Company’s shares for reported $0.2 million on Mar 27 ’24. In the deal valued at $3.72 per share,54,321 shares were bought. As a result of this transaction, Zanganeh Mahkam now holds 24,923,800 shares worth roughly $91.22 million. Then, Zanganeh Mahkam bought […]
A company insider recently bought 54,321 shares of Summit Therapeutics Inc [SMMT]. Should You Buy?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Summit Therapeutics Inc shares valued at $201,874 were purchased by Zanganeh Mahkam on Mar 27 ’24. At $3.72 per share, Zanganeh Mahkam acquired 54,321 shares. The insider’s holdings grew to 24,923,800 shares worth approximately […]
Summit Therapeutics Inc (SMMT) receives a Buy rating from Stifel
Summit Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Zanganeh Mahkam acquired Company’s shares for reported $0.2 million on Mar 27 ’24. In the deal valued at $3.72 per share,54,321 shares were bought. As a result of this transaction, Zanganeh Mahkam now holds 24,923,800 shares worth roughly $96.7 million. Then, Zanganeh Mahkam bought […]
SMMT Shares Experience Surge in Value
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Summit Therapeutics Inc shares valued at $201,874 were purchased by Zanganeh Mahkam on Mar 27 ’24. At $3.72 per share, Zanganeh Mahkam acquired 54,321 shares. The insider’s holdings grew to 24,923,800 shares worth approximately […]
Summit Therapeutics Inc (SMMT) rating initates by Stifel
Summit Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Zanganeh Mahkam acquired Company’s shares for reported $0.2 million on Mar 27 ’24. In the deal valued at $3.72 per share,54,321 shares were bought. As a result of this transaction, Zanganeh Mahkam now holds 24,923,800 shares worth roughly $103.18 million. Then, Zanganeh Mahkam bought […]
Summit Therapeutics Inc [SMMT] Investment Guide: What You Need to Know
In a filing, Summit Therapeutics Inc revealed its Chief Financial Officer Dhingra Ankur acquired Company’s shares for reported $44254.0 on Dec 13 ’23. In the deal valued at $2.17 per share,20,400 shares were bought. As a result of this transaction, Dhingra Ankur now holds 254,958 shares worth roughly $0.84 million. Then, Zanganeh Mahkam bought 5,000 […]
